Arbutus Biopharma to repurchase 46,000,000 shares for $230 million in modified Dutch auction
Arbutus Biopharma said it expects to repurchase 46,000,000 common shares for cancellation in a modified Dutch auction tender offer. The preliminary purchase price was set at US$ 5.00 per share, implying US$ 230 million in total consideration. The offer was oversubscribed, with 65,907,215 shares tendered at or below US$